Leng W, Wen Z, Wang H, Cao P, et al. Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial. BMC Cancer 2025;25:376.
PMID: 40022044